Duy Pham

1.2k total citations · 1 hit paper
22 papers, 441 citations indexed

About

Duy Pham is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Duy Pham has authored 22 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Duy Pham's work include Monoclonal and Polyclonal Antibodies Research (14 papers), CAR-T cell therapy research (13 papers) and Biosimilars and Bioanalytical Methods (5 papers). Duy Pham is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), CAR-T cell therapy research (13 papers) and Biosimilars and Bioanalytical Methods (5 papers). Duy Pham collaborates with scholars based in United States, Australia and Hong Kong. Duy Pham's co-authors include Sohye Yoon, Arti M. Raghubar, Xiao Tan, Laura F. Grice, Quan Nguyen, Pui Yeng Lam, Priyakshi Kalita‐de Croft, Emily F. Willis, Sunil R. Lakhani and Marc J. Ruitenberg and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Duy Pham

22 papers receiving 429 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Robust mapping of spatiotemporal trajectories and cell–cell interactions in healthy and diseased tissues

2023 177 citations Duy Pham, Xiao Tan et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Duy Pham United States	8	211	179	136	106	58	22	441
Vignesh Shanmugam United States	13	256 1.2×	138 0.8×	23 0.2×	84 0.8×	38 0.7×	36	629
Ritesh Parajuli United States	11	93 0.4×	195 1.1×	190 1.4×	35 0.3×	23 0.4×	27	529
Dragica Nikolić‐Vukosavljević Serbia	14	244 1.2×	264 1.5×	89 0.7×	34 0.3×	10 0.2×	51	510
He Ren China	12	148 0.7×	138 0.8×	58 0.4×	67 0.6×	12 0.2×	39	478
Meher Majety Germany	9	397 1.9×	280 1.6×	48 0.4×	106 1.0×	8 0.1×	13	724
Fabián Segovia‐Miranda Chile	10	134 0.6×	49 0.3×	61 0.4×	128 1.2×	14 0.2×	19	489
Vikram Adhikarla United States	10	105 0.5×	133 0.7×	97 0.7×	32 0.3×	9 0.2×	24	307
Qingda Meng Sweden	14	133 0.6×	419 2.3×	19 0.1×	308 2.9×	18 0.3×	36	667
Paola Dama United Kingdom	9	223 1.1×	180 1.0×	15 0.1×	118 1.1×	61 1.1×	18	448
Xiangwei Ge China	8	75 0.4×	106 0.6×	120 0.9×	27 0.3×	4 0.1×	23	403

Countries citing papers authored by Duy Pham

Since Specialization

Citations

This map shows the geographic impact of Duy Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duy Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duy Pham more than expected).

Fields of papers citing papers by Duy Pham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duy Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duy Pham. The network helps show where Duy Pham may publish in the future.

Co-authorship network of co-authors of Duy Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Duy Pham. A scholar is included among the top collaborators of Duy Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duy Pham. Duy Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Soohyun, Caelan E. Radford, Duo Xu, et al.. (2025). A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioning. Nature Communications. 16(1). 4617–4617. 1 indexed citations

Pham, Duy, Zezhuo Su, Melanie D. White, et al.. (2023). Inferring cell diversity in single cell data using consortium-scale epigenetic data as a biological anchor for cell identity. Nucleic Acids Research. 51(11). e62–e62. 2 indexed citations

Pham, Duy, Xiao Tan, Brad Balderson, et al.. (2023). Robust mapping of spatiotemporal trajectories and cell–cell interactions in healthy and diseased tissues. Nature Communications. 14(1). 7739–7739. 177 indexed citations breakdown →

Raghubar, Arti M., Duy Pham, Xiao Tan, et al.. (2022). Spatially Resolved Transcriptomes of Mammalian Kidneys Illustrate the Molecular Complexity and Interactions of Functional Nephron Segments. Frontiers in Medicine. 9. 873923–873923. 18 indexed citations

Buelow, Ben, Pranjali Dalvi, Kevin Dang, et al.. (2021). TNB585.001: A multicenter, phase 1, open-label, dose-escalation and expansion study of tnb-585, a bispecific T-cell engager targeting PSMA in subjects with metastatic castrate resistant prostate cancer.. Journal of Clinical Oncology. 39(15_suppl). TPS5092–TPS5092. 7 indexed citations

Boudreau, Andrew, Benjamin Buelow, Kevin Dang, et al.. (2021). TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL. mAbs. 13(1). 1890411–1890411. 22 indexed citations

Eteleeb, Abdallah M., David A. Quigley, Shuang G. Zhao, et al.. (2020). SV-HotSpot: detection and visualization of hotspots targeted by structural variants associated with gene expression. Scientific Reports. 10(1). 15890–15890. 2 indexed citations

Buelow, Ben, Kevin Dang, Pranjali Dalvi, et al.. (2020). Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release.. Journal of Clinical Oncology. 38(15_suppl). e17583–e17583. 1 indexed citations

Foureau, David, Manisha Bhutani, Fei Guo, et al.. (2020). Ex vivo efficacy of BCMA‐bispecific antibody TNB‐383B in relapsed/refractory multiple myeloma. SHILAP Revista de lepidopterología. 1(1). 113–121. 20 indexed citations

10.

Buelow, Ben, Andrew Boudreau, Laura Davison, et al.. (2020). A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release.. Journal of Clinical Oncology. 38(15_suppl). e18050–e18050. 1 indexed citations

11.

Buelow, Ben, Udaya S. Rangaswamy, Andrew Boudreau, et al.. (2019). TNB-486, a Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills CD19-Positive Tumor Cells with Minimal Cytokine Secretion. Blood. 134(Supplement_1). 4070–4070. 6 indexed citations

12.

Trinklein, Nathan D., Duy Pham, Ute Schellenberger, et al.. (2019). Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. mAbs. 11(4). 639–652. 82 indexed citations

13.

Clarke, Starlynn, Kevin Dang, Yuping Li, et al.. (2019). A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release.. Journal of Clinical Oncology. 37(7_suppl). 324–324. 2 indexed citations

14.

Buelow, Ben, Starlynn Clarke, Kevin Dang, et al.. (2018). Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma.. Journal of Clinical Oncology. 36(15_suppl). 8034–8034. 19 indexed citations

15.

Foureau, David, Manisha Bhutani, Fei Guo, et al.. (2018). Ex Vivo Assessment of Tnb-383B, a Bcma-Bispecific Antibody, Against Primary Tumor and Endogenous T Cells from Relapsing Multiple Myeloma Patients. Blood. 132(Supplement 1). 1940–1940. 4 indexed citations

16.

Rangaswamy, Udaya S., Andrew Boudreau, Ben Buelow, et al.. (2018). A novel T-cell bispecific antibody platform for efficient T-cell mediated killing of tumor cells with minimal cytokine release.. Journal of Clinical Oncology. 36(5_suppl). 209–209. 4 indexed citations

17.

Aldred, Shelley Force, Andrew Boudreau, Ben Buelow, et al.. (2018). Multispecific antibodies targeting CD38 show potent tumor-specific cytotoxicity.. Journal of Clinical Oncology. 36(5_suppl). 57–57. 2 indexed citations

18.

Buelow, Ben, Duy Pham, Starlynn Clarke, et al.. (2017). Development of a fully human T cell engaging bispecific antibody for the treatment of multiple myeloma.. Journal of Clinical Oncology. 35(15_suppl). 8017–8017. 5 indexed citations

19.

Chee, Youngjoon, et al.. (2016). A Virtual Blind Cane Using a Line Laser-Based Vision System and an Inertial Measurement Unit. Sensors. 16(1). 95–95. 39 indexed citations

20.

Pham, Duy, et al.. (2000). Technique for Selecting Examples in Inductive Learning. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact